Locating the active site for angiogenesis and cell proliferation due to fibrin fragment E with a phage epitope display library

General Pharmacology: Vascular System

Volumn 35, Issue 5, 2000, Pages 261-267

  Stirk, C M ^a,b   Reid, A ^a   Melvin, W T ^a   Thompson, W D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Angiogenesis; Atherosclerosis; Cancer; Cell proliferation; Chronic inflammation; Fibrin degradation products; Fibrinogen; Fibrinolysis; Wound healing

Indexed keywords

ANTIBODY; CYSTEINYLARGINYLALANYLHISTIDYLSERYLPHENYLALANYLGLYCYLSERYLPROLYLARGINYLPROL YLLEUCYLPROLYLVALYLVALINE; EPITOPE; FIBRIN DEGRADATION PRODUCT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; CELL ACTIVITY; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL DIVISION; CHICK EMBRYO; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INOVIRUS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE LIBRARY; RABBITS; RATS;

EID: 0034581637     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(01)00114-8     Document Type: Conference Paper

References (20)

1. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro
2. VEGF gene therapy: Stimulating angiogenesis or angioma-genesis?
3. Expression of Wnt genes in early wound healing
4. VEGF gene therapy to myocardium: Deleterious effects of unregulated expression
5. Smooth muscle cell outgrowth stimulated by fibrin degradation products: The potential role of fibrin fragment E in restenosis and atherogenesis
6. Antibody-selectable filamentous Fd phage vectors - Affinity purification of target genes
7. Antimetastatic agents: I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment
8. Searching for peptide ligands with an epitope library
9. Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques
10. Quantitative assays for the chick chorioallantoic membrane
11. Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane
12. Angiogenic activity of fibrin degradation products is located in fibrin fragment E
13. Fibrin degradation products in growth stimulatory extracts of pathological lesions
14. Wound healing, fibrin and angiogenesis
15. Fibrin degradative pathways in healing, atherosclerosis and tumour invasion
16. The clinical manipulation of angiogenesis: Pathology, side effects, surprises and opportunities with novel human therapies
17. Crystal structure of native chicken fibrinogen at 5.5-A resolution
18. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides
19. Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung
20. Coagulation-cancer interaction in situ in renal cell carcinoma